Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/10/2018
SIETES contiene 92571 citas

 
 
 1 a 20 de 20 
Presentar resultados
Seleccionar todas
4.Tiene citas relacionadas Cita con resumen
Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, Wetterslev J. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 2013;346:1212. [Ref.ID 95405]
5.Tiene citas relacionadas Cita con resumen
Prowle JR, Pearse RM. Is it the end of the road for synthetic starches in critical illness?. BMJ 2013;346:10. [Ref.ID 95404]
6.Tiene citas relacionadas Cita con resumen
Myburgh J, Finfer S, Billot L. Hydroxyethyl starch or saline in intensive care. Author/editor response. N Engl J Med 2013;368:775. [Ref.ID 94970]
7.Tiene citas relacionadas Cita con resumen
Raghunathan K, Shaw A. Hydroxyethyl starch or saline in intensive care. N Engl J Med 2013;368:774-5. [Ref.ID 94969]
8.Tiene citas relacionadas Cita con resumen
Guidet B. Hydroxyethyl starch or saline in intensive care. N Engl J Med 2013;368:774. [Ref.ID 94968]
9.
Antonelli M, Sandroni C. Hydroxyethyl starch for intravenous volume replacement: more harm than benefit. JAMA 2013;309:723-4. [Ref.ID 94959]
10. Cita con resumen
Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, Fergusson DA. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a sytematic review and meta-analysis. JAMA 2013;309:678-88. [Ref.ID 94957]
11.Tiene citas relacionadas Cita con resumen
Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SAR, for the CHEST Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367:1901-11. [Ref.ID 94068]
12.Enlace a cita original
Shi XY, Zou Z, He X-Y, Xu HT, Yuan HB, Liu H. Hydroxyethyl starch for cardiovascular surgery: a systematic review of randomized controlled trials. Eur J Clin Pharmacol 2011;67:767-82. [Ref.ID 91081]
13. Cita con resumen
Ebo DG, Fisher MM, Hagendorens MM, Bridts CH, Stevens WJ. Anaphylaxis during anaesthesia: diagnostic approach. Allergy 2007;62:471-87. [Ref.ID 78290]
15.Tiene citas relacionadas
Bernal W, Wendon JA. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet 2001;358:583. [Ref.ID 58259]
16.Tiene citas relacionadas
Schortgen F, Brochard L. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Authors' reply. Lancet 2001;358:582. [Ref.ID 58258]
17.Tiene citas relacionadas
18.Tiene citas relacionadas
19.Tiene citas relacionadas
Gosling P, Rittoo D, Manji M, Mahmood A, Vohra R. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet 2001;358:581. [Ref.ID 58255]
20. Cita con resumen
Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911-6. [Ref.ID 55760]
Seleccionar todas
 
 1 a 20 de 20